Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
High-dose Ivermectin for Reducing Malaria Transmission
NCT02511353Phase 2Completed
- Sponsor
- Liverpool School of Tropical Medicine
- Start
- Jul 2015
- Primary completion
- Jul 2016
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial of ivermectin in malaria (3 arms), sponsored by Liverpool School of Tropical Medicine. Primary endpoint: Mosquito survival at 14 days. Started Jul 2015; status: completed.
02
Drugs
ivermectin
03
Conditions
malaria
Beyond the preview
Go deeper on NCT02511353.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02511353.